Tag-Assisted Peptide Synthesis (TAPS) Services Market Size, Share Detailed Report 2025 to 2034

Global Tag-Assisted Peptide Synthesis (TAPS) Services Market Size is predicted to grow at a 9.2 % CAGR during the forecast period for 2025 to 2034.

Tag-Assisted Peptide Synthesis (TAPS) Services Market Share & Trends Analysis Report, By Technology (Chemical Synthesis with Tags, Hybrid Synthesis, C-Terminal Amidation Synthesis), By Application (Therapeutics, Drug Discovery, Research), By End-User, By Region, and Segment Forecasts, 2025 to 2034 

Tag-Assisted Peptide Synthesis (TAPS) services involve specialized methods for synthesizing peptides using chemical or molecular tags to enhance efficiency, solubility, and purification throughout the synthesis process. These services, offered by companies and research laboratories, support applications in drug discovery, therapeutic development, and advanced peptide research.

The use of tags allows for selective precipitation or phase separation, significantly reducing the need for complex and time-consuming purification methods such as chromatography. This approach streamlines the isolation of pure peptides, conserving both time and resources. Additionally, TAPS employs soluble tags to improve peptide solubility in organic solvents like cyclopentyl methyl ether (CPME), enabling efficient coupling reactions, particularly for hydrophobic or aggregation-prone sequences that pose challenges in conventional solid-phase peptide synthesis (SPPS).

The Hybrid Synthesis approach plays a pivotal role in the Tag-Assisted Peptide Synthesis (TAPS) services market by combining the strengths of solid-phase peptide synthesis (SPPS) and liquid-phase peptide synthesis (LPPS), often enhanced by the use of chemical or molecular tags. This method addresses the limitations of traditional synthesis techniques, enabling the efficient production of complex, long, and modified peptides for various applications. Hybrid synthesis integrates SPPS for initial peptide elongation with tag-assisted LPPS for purification and further modifications, leveraging tags (e.g., silylated STags, hydrophobic benzyl alcohols) to enhance solubility and streamline purification. This results in higher yields and scalability for complex peptides. Tags in hybrid synthesis enable selective precipitation or phase separation, simplifying purification compared to SPPS, which often requires complex chromatography. This reduces solvent use and aligns with green chemistry principles, a key driver in the TAPS market.

Simultaneously, the rising prevalence of chronic diseases such as cancer, diabetes, cardiovascular disorders, and neurological conditions is fueling demand for peptide-based therapeutics due to their high specificity, low toxicity, and favorable pharmacokinetic profiles. Tag-Assisted Peptide Synthesis (TAPS) plays a critical role in enabling the synthesis of complex peptides, including cyclic peptides like eptifibatide and icatibant acetate, which are increasingly used in such treatments. Additionally, advancements in automation and high-throughput platforms, such as microwave-assisted synthesis and continuous one-pot elongation systems like STag-PS, are streamlining TAPS workflows, boosting scalability, reducing production time, and supporting broader adoption in drug development.

Competitive Landscape

Some of the Major Key Players in the Tag-Assisted Peptide Synthesis (TAPS) Services Market are :

• Bachem
• CordenPharma
• Biosynth (Pepscan)
• AmbioPharm
• GenScript
• CPC Scientific
• PolyPeptide Group
• TAG Copenhagen A/S
• CSBio
• Auspep
• BCN Peptides
• Peptide Institute
• Creative Peptides
• Aurigene Services

Market Segmentation

The tag-assisted peptide synthesis (taps) services market is segmented based on technology, application, end-user, and end-user. Based on technology, the market is segmented into chemical synthesis with tags, hybrid synthesis, and c-terminal amidation synthesis. Based on the application, the market is divided into therapeutics, drug discovery, and research. Based on end-user, the market is divided into pharmaceutical and biotechnology companies, CDMOs/CROs, and academic and research institutes.

The Chemical Synthesis Segment is Expected to Have the Highest Growth Rate During the Forecast Period

Based on Technology, the market is segmented into chemical synthesis with tags, hybrid synthesis, and c-terminal amidation synthesis. Among these, the chemical synthesis segment is expected to have the highest growth rate during the forecast period. Chemical synthesis with tags is the foundational approach in Tag-Assisted Peptide Synthesis (TAPS), utilizing solid-phase peptide synthesis (SPPS) enhanced by solubilizing or protective tags to boost efficiency, particularly for long, hydrophobic, or aggregation-prone peptides. These tags significantly improve peptide solubility in organic solvents, which reduces side reactions and facilitates cleaner chain elongation, ultimately leading to higher purity and yield. This method also minimizes the need for complex downstream purification processes. Furthermore, chemical synthesis with tags is highly versatile, accommodating both small-scale research needs and large-scale commercial manufacturing. Its compatibility with automated peptide synthesizers enhances reproducibility and ensures cost-effective production, making it a leading solution in the peptide synthesis services market.

The Therapeutics Segment Dominates the Market

Based on the application, the market is divided into therapeutics, drug discovery, and research.  Among these, the therapeutics segment dominates the market. The growing prevalence of chronic diseases such as cancer, diabetes, cardiovascular disorders, and autoimmune conditions has significantly accelerated the development of peptide-based therapeutics, valued for their high specificity, low toxicity, and favorable safety profiles. However, many of these therapeutic peptides, such as cyclic peptides, multi-disulfide peptides, and long-chain peptides, pose significant challenges during synthesis using conventional methods due to their structural complexity and poor solubility. Tag-Assisted Peptide Synthesis (TAPS) overcomes these limitations by enabling efficient and scalable production, enhancing solubility, minimizing aggregation, and improving overall yield, making it an essential technique in the manufacturing of modern peptide therapeutics.

North America Has the Largest Market Share During the Forecast Period.

North America is the market leader in the Tag-Assisted Peptide Synthesis (TAPS) Services Market due to its advanced life sciences ecosystem, robust R&D investments, and strong regulatory and commercial infrastructure. The United States, which is dedicated to contract manufacturing organizations (CMOs/CDMOs) and world leaders in peptide drug development, is a significant center for peptide therapies innovation and demand. The region benefits from significant investments in life sciences, personalized medicine, and biologics, which in turn drive the need for advanced synthesis technologies like Tag-Assisted Peptide Synthesis (TAPS). Additionally, the U.S. Food and Drug Administration (FDA) offers streamlined regulatory pathways for peptide drug approvals, further encouraging development and commercialization. The growing number of peptide-based clinical trials across therapeutic areas reinforces North America’s leadership in the TAPS services market.

Recent Developments:

• In November 2024, AmbioPharm broke ground on a $28?million expansion at its Shanghai facility, adding 70,000?ft² of space equipped with multiple 1,000–3,000?L reactors capable of both solid-phase and liquid-phase peptide synthesis (SPPS & LPPS). This expansion is expected to enable the production of over 8 metric tons of crude peptide annually, covering fragment-based peptide synthesis workflows and supporting downstream purification, thereby reinforcing its capacity in Chemical Synthesis with Tags and Hybrid Synthesis.

• In September 2023, CordenPharma stated to have finished many facility improvements and modernizations that have improved the productivity and efficiency of SPPS peptide manufacturing, enabling a greater ability to serve both present and potential clients across an expanding range of pharmaceutical innovators. Upgrades to the current 10,000 l reactor volume with a batch size exceeding 400 kg and an annual capacity of over 2 metric tons of peptide were among the measures put into place; a 50% increase in downstream HPLC purification capacity; automation upgrades; the use of PAT for amino acid identification and intensification of the ready-to-use process with constant washing and reaction monitoring.

Tag-Assisted Peptide Synthesis (TAPS) Services Market Report Scope :